HomeNewscoronavirusXE sub-variant not lethal, infected man asymptomatic: Maharashtra Health Minister

XE sub-variant not lethal, infected man asymptomatic: Maharashtra Health Minister

Talking to media persons in Jalna, Tope said a 67-year-old man and his wife who had been in Mumbai tested positive for coronavirus in Gujarat last month.

April 09, 2022 / 21:47 IST
Representative image

Maharashtra Health Minister Rajesh Tope on Saturday said that Omicron sub-variant XE is not lethal and the only case detected in the state of an elderly man is asymptomatic.

Talking to media persons in Jalna, Tope said a 67-year-old man and his wife who had been in Mumbai tested positive for coronavirus in Gujarat last month.

"The man had arrived from London on March 6 and came in contact with two Britishers. On March 11, he experienced a mild fever. On March 12, he was tested during his stay in Vadodara and the sample was sent for genome sequencing to the Gujarat Biotechnology Research Centre," Tope said.

The health minister further said that the elderly man developed a fever on March 13 and returned to Mumbai the following day.

Tope said three other persons in Gujarat who came in contact with the infected man were tested but they were found negative and without the (XE) sub-variant.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"The man has been in quarantine at his home in Mumbai since March 20. He is asymptomatic. He had taken two doses (of the anti-COVID-19 vaccine). He is suffering from hypertension. There is no worry about the new variant, it is not lethal," he added.

According to Gujarat government officials, the man was found infected with the XE variant as per a report given by a Gandhinagar-based laboratory, which was cross-checked and confirmed by a facility in Kolkata on Friday. Responding to a query for the booster dose for adults in the age group of 15 to 59 years, Tope said the booster dose is not needed for this age category.

"But those who want to take the booster dose can take it from private hospitals. The government has no responsibility regarding the administration of the booster dose to people in the 15 to 59 age group," he added.

The World Health Organisation (WHO) has said that XE could be more transmissible than any COVID-19 strain so far. XE is a combination or a recombinant of both sub-variants (BA.1 and BA.2) of Omicron.

PTI
first published: Apr 9, 2022 09:47 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
CloseOutskill Genai